Company news

Sareum Holdings plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Result of WRAP Retail Offer

April 2, 2024

Increase in size of WRAP Retail Offer

April 2, 2024

WRAP Retail Offer

March 28, 2024

Equity Fundraise

March 28, 2024

New Patent Allowance

March 15, 2024

Notice of Interim Results and Trading Update

March 12, 2024

Update on SDC-1801 Clinical Trial Progress

February 15, 2024

Development and commercialisation licence SRA737

January 2, 2024

Drawdown of Equity Prepayment Facility

November 23, 2023

Initiation of food effects study for SDC-1801

November 9, 2023

Director Dealings

November 8, 2023

Sareum enhances SDC-1801 patent protection

November 3, 2023

Exercise of Share Options and Director Dealings

November 2, 2023

Final Results for the Year Ended 30 June 2023

October 9, 2023

Director's Dealing

September 6, 2023

Director Dealing

September 5, 2023

Dosing of first subjects in MAD Phase 1a trial

September 4, 2023

Update on financial and operational progress

August 16, 2023

Equity Prepayment Facility of up to £5 million

August 3, 2023

Sareum Announces Two New Granted Patents

June 26, 2023

Dosing commences in Phase 1a trial of SDC-801

June 6, 2023

Phase 1a clinical trial for SDC-1801

May 18, 2023

Approval to initiate Phase 1 clinical trial

May 5, 2023

Half-Year Report

March 22, 2023

Update on SDC-1801

March 15, 2023

Notice of Half-Year Results

March 15, 2023

Director/PDMR Shareholding

December 29, 2022

AGM Statement

December 16, 2022

Sareum notes publication of SRA737 clinical data

November 21, 2022

Second Price Monitoring Extn

November 9, 2022

Price Monitoring Extension

November 9, 2022

Update on SDC-1801 CTA Application

November 8, 2022

Final Results for the Year Ended 30 June 2022

October 24, 2022

Update on SAR737

October 12, 2022

Sareum notes FDA approval of first TYK2 Inhibitor

September 12, 2022

CTA application to MHRA and Corporate Update

July 28, 2022

Sareum notes GSK's completed acquisition of Sierra

July 4, 2022

Sareum to Present at BioTrinity 2022 Conference

April 26, 2022

Sareum notes acquisition of Sierra Oncology by GSK

April 13, 2022

European Patent Granted for Sareum's SDC-1802

April 11, 2022

SDC-1801: Preclinical Toxicology Report Received

March 16, 2022

Results of EGM

February 28, 2022

Half-year Report

February 21, 2022

Publication of Circular; Notice of General Meeting

February 4, 2022

Correction - Issue of Warrants

January 28, 2022

Issue of Warrants

January 28, 2022

Sareum to Participate in Edison Open House Event

January 25, 2022

Subscription to raise £1.63m to progress SDC-1801

December 17, 2021

Result of AGM

December 16, 2021

Intention to grant notice - EU patent for SDC-1802

December 15, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 13 calls. Every call is listed under its year.

Decks

The 5 newest of 8 decks. Every deck is listed under its year.